ARCHIVES

CAB Reluctantly Approves Use Of Contract To Support Cancer Journals

This article is from The Cancer Letter archive.

Vol. 11 No. 07 | February 15, 1985

Download PDF Visit The Full Archive

Related Articles

In Brief: Benjamin Neel named director of NYU Cancer Center

October 24, 2014

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

January 7, 2005

CCIRC Disapproves NCOG Renewal, But Carter Plan Appeal To NCAB; Setback For NCI On Regional Groups

March 6, 1981

DCT Board Okays $3 Million In New Programs, $8 Million In Recompetitions

October 24, 1980

BRMP Workshops Planned; DCT Board Balk At Size of Intramural Budget

November 28, 1980

Clinical Trials: “Master Protocol” To Rely On Biomarkers In Testing Multiple Lung Cancer Agents

November 15, 2013